116 related articles for article (PubMed ID: 37634741)
21. Identification and Characterization of a Ribose 2'-O-Methyltransferase Encoded by the Ronivirus Branch of Nidovirales.
Zeng C; Wu A; Wang Y; Xu S; Tang Y; Jin X; Wang S; Qin L; Sun Y; Fan C; Snijder EJ; Neuman BW; Chen Y; Ahola T; Guo D
J Virol; 2016 Aug; 90(15):6675-6685. PubMed ID: 27170751
[TBL] [Abstract][Full Text] [Related]
22. Sequestration by IFIT1 impairs translation of 2'O-unmethylated capped RNA.
Habjan M; Hubel P; Lacerda L; Benda C; Holze C; Eberl CH; Mann A; Kindler E; Gil-Cruz C; Ziebuhr J; Thiel V; Pichlmair A
PLoS Pathog; 2013; 9(10):e1003663. PubMed ID: 24098121
[TBL] [Abstract][Full Text] [Related]
23. Mn
Minasov G; Rosas-Lemus M; Shuvalova L; Inniss NL; Brunzelle JS; Daczkowski CM; Hoover P; Mesecar AD; Satchell KJF
Sci Signal; 2021 Jun; 14(689):. PubMed ID: 34131072
[TBL] [Abstract][Full Text] [Related]
24. SARS-CoV-2 Nsp16 activation mechanism and a cryptic pocket with pan-coronavirus antiviral potential.
Vithani N; Ward MD; Zimmerman MI; Novak B; Borowsky JH; Singh S; Bowman GR
bioRxiv; 2020 Dec; ():. PubMed ID: 33330873
[TBL] [Abstract][Full Text] [Related]
25. Identification and structural studies of natural inhibitors against SARS-CoV-2 viral RNA methyltransferase (NSP16).
Kumar M; Roy A; Rawat RS; Alok A; Tetala KKR; Biswas NR; Kaur P; Kumar S
J Biomol Struct Dyn; 2022; 40(24):13965-13975. PubMed ID: 34766876
[TBL] [Abstract][Full Text] [Related]
26. Peptide inhibitors against SARS-CoV-2 2'-O-methyltransferase involved in RNA capping: A computational approach.
Dutta M; Iype E
Biochem Biophys Rep; 2021 Sep; 27():101069. PubMed ID: 34250275
[TBL] [Abstract][Full Text] [Related]
27. Structural analysis, virtual screening and molecular simulation to identify potential inhibitors targeting 2'-O-ribose methyltransferase of SARS-CoV-2 coronavirus.
Jiang Y; Liu L; Manning M; Bonahoom M; Lotvola A; Yang Z; Yang ZQ
J Biomol Struct Dyn; 2022 Feb; 40(3):1331-1346. PubMed ID: 33016237
[TBL] [Abstract][Full Text] [Related]
28. SARS-CoV-2 Nsp16 activation mechanism and a cryptic pocket with pan-coronavirus antiviral potential.
Vithani N; Ward MD; Zimmerman MI; Novak B; Borowsky JH; Singh S; Bowman GR
Biophys J; 2021 Jul; 120(14):2880-2889. PubMed ID: 33794150
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of adenine dinucleosides SAM analogs as specific inhibitors of SARS-CoV nsp14 RNA cap guanine-N7-methyltransferase.
Ahmed-Belkacem R; Sutto-Ortiz P; Guiraud M; Canard B; Vasseur JJ; Decroly E; Debart F
Eur J Med Chem; 2020 Sep; 201():112557. PubMed ID: 32563813
[TBL] [Abstract][Full Text] [Related]
30. Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease.
Agostini ML; Andres EL; Sims AC; Graham RL; Sheahan TP; Lu X; Smith EC; Case JB; Feng JY; Jordan R; Ray AS; Cihlar T; Siegel D; Mackman RL; Clarke MO; Baric RS; Denison MR
mBio; 2018 Mar; 9(2):. PubMed ID: 29511076
[TBL] [Abstract][Full Text] [Related]
31. Identification of novel mutations in the methyltransferase complex (Nsp10-Nsp16) of SARS-CoV-2.
Azad GK
Biochem Biophys Rep; 2020 Dec; 24():100833. PubMed ID: 33072893
[TBL] [Abstract][Full Text] [Related]
32. Crystal structure of SARS-CoV-2 nsp10-nsp16 in complex with small molecule inhibitors, SS148 and WZ16.
Klima M; Khalili Yazdi A; Li F; Chau I; Hajian T; Bolotokova A; Kaniskan HÜ; Han Y; Wang K; Li D; Luo M; Jin J; Boura E; Vedadi M
Protein Sci; 2022 Sep; 31(9):e4395. PubMed ID: 36040262
[TBL] [Abstract][Full Text] [Related]
33. Human IFIT1 Inhibits mRNA Translation of Rubulaviruses but Not Other Members of the Paramyxoviridae Family.
Young DF; Andrejeva J; Li X; Inesta-Vaquera F; Dong C; Cowling VH; Goodbourn S; Randall RE
J Virol; 2016 Oct; 90(20):9446-56. PubMed ID: 27512068
[TBL] [Abstract][Full Text] [Related]
34. Structural insight into the recognition of
Mahalapbutr P; Kongtaworn N; Rungrotmongkol T
Comput Struct Biotechnol J; 2020; 18():2757-2765. PubMed ID: 33020707
[TBL] [Abstract][Full Text] [Related]
35. In vitro reconstitution of SARS-coronavirus mRNA cap methylation.
Bouvet M; Debarnot C; Imbert I; Selisko B; Snijder EJ; Canard B; Decroly E
PLoS Pathog; 2010 Apr; 6(4):e1000863. PubMed ID: 20421945
[TBL] [Abstract][Full Text] [Related]
36. NSP16 2'-O-MTase in Coronavirus Pathogenesis: Possible Prevention and Treatments Strategies.
Chang LJ; Chen TH
Viruses; 2021 Mar; 13(4):. PubMed ID: 33804957
[TBL] [Abstract][Full Text] [Related]
37. Substrate Specificity of SARS-CoV-2 Nsp10-Nsp16 Methyltransferase.
Benoni R; Krafcikova P; Baranowski MR; Kowalska J; Boura E; Cahová H
Viruses; 2021 Aug; 13(9):. PubMed ID: 34578302
[TBL] [Abstract][Full Text] [Related]
38. Live attenuated coronavirus vaccines deficient in N7-Methyltransferase activity induce both humoral and cellular immune responses in mice.
Zhang Z; Liu Q; Sun Y; Li J; Liu J; Pan R; Cao L; Chen X; Li Y; Zhang Y; Xu K; Guo D; Zhou L; Lan K; Chen Y
Emerg Microbes Infect; 2021 Dec; 10(1):1626-1637. PubMed ID: 34365904
[TBL] [Abstract][Full Text] [Related]
39. Short peptides derived from the interaction domain of SARS coronavirus nonstructural protein nsp10 can suppress the 2'-O-methyltransferase activity of nsp10/nsp16 complex.
Ke M; Chen Y; Wu A; Sun Y; Su C; Wu H; Jin X; Tao J; Wang Y; Ma X; Pan JA; Guo D
Virus Res; 2012 Aug; 167(2):322-8. PubMed ID: 22659295
[TBL] [Abstract][Full Text] [Related]
40. Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics.
Smith EC; Blanc H; Surdel MC; Vignuzzi M; Denison MR
PLoS Pathog; 2013 Aug; 9(8):e1003565. PubMed ID: 23966862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
